Ada Health and Santéclair announce partnership extension

AI health assessment platform Ada Health has announced a three-year extension to its partnership with French health services management company, Santéclair.

The partnership with Ada Health allows Santéclair’s 10 million members to continue using Ada’s automated care navigation technology through MySantéclair, the French company’s digital health platform.

Christian Acknin, director-general of Santéclair, said: “Our aim at Santéclair has always been to promote access to quality care for all. Extending this partnership and increasing the range of services that Ada’s AI can direct our insurance partners’ members towards will help us continue supporting them through all stages of their healthcare journey”.

Santéclair connects members to more than 150,000 healthcare providers in France, including specialists in women’s health, mental health, dental care, screening, and preventative services. Ada’s AI technology factors in members’ insurance coverage to direct them to the most appropriate care within this network.

First signed in 2021, the partnership spans some 60 insurance plans and aims to help members make informed decisions about their care, connecting them to cost-effective services, whether virtual or in-person.

Nicholas Altebrando, chief product officer at Ada Health, said: “We’re seeing growing demand from patients and consumers for safe, reliable digital tools that work with individuals’ insurance plans and allow them to take control of their care journey.

“That is exactly what our partnership with Santéclair delivers and we’re excited to be expanding our work together as we continue to grow as a business in Europe and globally. 

“We’ve already connected thousands of people covered by Santéclair’s 60 insurance partners to access cost-effective services, based on their plans and care needs, and are looking forward to scaling this further”.

Services covered by the partnership include specialists in mental health, women’s health, ophthalmology, and osteopathy; condition-specific treatments for endometriosis, depression, and lower-back pain; preventative services such as smoking cessation, dieticians, sleep therapy, and wellness coaching; and patient education for self-management.

Since its founding in 2011, Berlin-based Ada Health has grown to become one of the most significant health AI companies in Europe.

In February 2022, Ada Health secured £88.5 million ($120m) in Series B funding, to accelerate rapid growth, particularly in the US.

The company’s solution was certified as a Class IIa medical device under the European Union Medical Device Regulation (EU-MDR), in December 20222, meaning it meets the regulatory requirements for safety and performance as a medical device and can be officially used in the diagnosis and management of health conditions.